Biovest International Report issue

For profit Phase 3
Founded: Tampa FL United States (1981)
Status: Left NME R&D (2010)

Organization Overview

First Clinical Trial
2000
NCT00091676
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

fnhlid1 (BiovaxID) (1 trial)

keyhole limpet hemocyanin (1 trial)

sargramostim (leukine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 3)

Lymphoma, Follicular (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3